What proportion of patients with chronic heart failure are eligible for sacubitril-valsartan?-Reference-Cited by-同舟云学术

What proportion of patients with chronic heart failure are eligible for sacubitril-valsartan?

Published:2017-02-27 Issue:6 Volume:19 Page:768-778
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:Eur J Heart Fail

Author:

Pellicori Pierpaolo¹,Urbinati Alessia¹,Shah Parin¹,MacNamara Alexandra¹,Kazmi Syed¹,Dierckx Riet¹,Zhang Jufen¹,Cleland John G.F.¹²,Clark Andrew L.¹

Affiliation:

1. Department of Cardiology, Castle Hill Hospital; Hull York Medical School (at University of Hull); Kingston upon Hull UK

2. National Heart & Lung Institute and National Institute of Health Research Cardiovascular Biomedical Research Unit; Royal Brompton & Harefield Hospitals, Imperial College; London UK

Funder

Società Italiana di Cardiologia (Borsa di studio SIC e MSD Italia-Merck Sharp & Dohme Corporation)

Novartis

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ejhf.788/fullpdf

Reference24 articles.

1. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC;Ponikowski;Eur J Heart Fail,2016

2. Angiotensin-neprilysin inhibition versus enalapril in heart failure;McMurray;N Engl J Med,2014

3. Clinical trials update from the European Society of Cardiology meeting 2014: PARADIGM-HF, CONFIRM-HF, SIGNIFY, atrial fibrillation, beta-blockers and heart failure, and vagal stimulation in heart failure;Clark;ESC Heart Fail,2014

4. Heart Failure Association (HFA) of the European Society of Cardiology (ESC). European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT): 1-year follow-up outcomes and differences across regions;Crespo-Leiro;Eur J Heart Fail,2016

5. Improvement programme in evaluation and management; Study Group on Diagnosis of the Working Group on Heart Failure of The European Society of Cardiology. Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey;Cleland;Lancet,2002

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rationale and protocol of the LAQUA-HF trial: a factorial randomised controlled trial evaluating the effects of neurohormonal and diuretic agents on health-status reported outcomes in heart failure patients;BMJ Open;2024-02

2. Effects of Angiotensin Receptor-Neprilysin Inhibitors Versus Enalapril or Valsartan on Patients With Heart Failure: A Systematic Review and Meta-Analysis;Cureus;2023-07-08

3. Herzerkrankungen;Arzneiverordnungs-Report 2023;2023

4. Which frailty tool best predicts morbidity and mortality in ambulatory patients with heart failure? A prospective study;European Heart Journal - Quality of Care and Clinical Outcomes;2022-11-17

5. Brain Natriuretic Peptide Biomarkers in Current Clinical and Therapeutic Scenarios of Heart Failure;Journal of Clinical Medicine;2022-06-02